Skip to main content
Premium Trial:

Request an Annual Quote

3D Pharma, DuPont in Discovery Collaboration, 3D Gets Screening Patent



XTON, Pa.--3-Dimensional Pharmaceuticals and DuPont Pharmaceuticals have formed a collaboration through which 3DP will use its DirectedDi-versity technology to assist DuPont in the discovery of new drugs for specific biological targets. 3DP will apply its iterative drug discovery process to generate custom combinatorial chemistry libraries based on molecules and information provided by DuPont and will optimize those molecules into preclinical drug candidates. For the initial target, 3DP will receive payments of up to $9 million, including an up-front technology access fee, research and development funding, and milestone payments. DuPont will also take a nonexclusive license to 3DP’s Directed Discovery drug discovery patents.

In other news, 3DP received a patent for its ThermoFluor technology, a method of obtaining quantitative measurements of drug-binding affinity to almost any protein or nucleic acid target.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.